Last Price
131.06
Today's Change
+2.93 (2.28%)
Day's Change
126.36 - 131.57
Trading Volume
547,904
Market Cap
7 Billion
Shares Outstanding
59 Million
Avg Volume
418,233
Avg Price (50 Days)
132.34
Avg Price (200 Days)
134.05
PE Ratio
-17.04
EPS
-7.69
Earnings Announcement
05-Feb-2025
Previous Close
128.13
Open
128.55
Day's Range
126.3675 - 131.57
Year Range
111.09 - 161.0
Trading Volume
547,904
1 Day Change
2.29%
5 Day Change
-2.72%
1 Month Change
-3.90%
3 Month Change
1.87%
6 Month Change
-3.07%
Ytd Change
-5.03%
1 Year Change
-2.31%
3 Year Change
21.39%
5 Year Change
-6.32%
10 Year Change
596.02%
Max Change
596.02%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.